Civic Intelligence

New York Metropolitan Endometriosis Research Incorporated

EIN 26-1389461 • 501(c)3 • Brooklyn, NY

Profile

The purpose of this corporation is clinical and scientific research for the treatment of endometriosis and infertility. Funds from the corporation will allow scientists to conduct laboratory and clinical research leading toward a cure and treatment for endometriosis and to promote novel treatment for infertility.

41 S 5th Street No 11Brooklyn, NY 11249

n/A

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2014

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.

Source year 2014

Net Margin

Score unavailable

No value available

Net margin requires both revenue and expenses on the latest valid filing.

Source year 2014

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2014

Asset Growth

13th percentile

-82%

Faster asset growth than 13% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Revenue Growth

Score unavailable

No value available

A valid growth rate could not be computed from the available filing history.

Annualized from 2013 to 2014

Balance Sheet
Liabilities / Assets60th percentile

Assets

Down

$5,060

Down $22,739 (-82%) from 2013

Liabilities

Flat

$0

Flat from 2013

Net Assets

Down

$5,060

Down $22,739 (-82%) from 2013

Operations
Liabilities / RevenueScore unavailableNet MarginScore unavailable

Revenue

Flat

$0

Flat from 2013

Expenses

Up

$22,739

Up $22,739 from 2013

Net Income

Down

-$22,739

Down $22,739 from 2013

Trend Graphs

Balance Sheet Trend

Asset Growth13th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$30K$20K$10K$0Assets 2012: $27,799Liabilities 2012: $0Net Assets 2012: $27,7992012Assets 2013: $27,799Liabilities 2013: $0Net Assets 2013: $27,7992013Assets 2014: $5,060Liabilities 2014: $0Net Assets 2014: $5,0602014

Highlighted filing

2014

Assets$5,060
Liabilities$0
Net Assets$5,060
Open 2014 Filing

Operations Trend

Revenue GrowthScore unavailable

Revenue, expenses, and net income by year, with the latest filing highlighted.

$40K$20K$0-$20K-$40KExpenses 2012: $02012Revenue 2013: $0Expenses 2013: $0Net Income 2013: $02013Revenue 2014: $0Expenses 2014: $22,739Net Income 2014: -$22,7392014

Highlighted filing

2014

Revenue$0
Expenses$22,739
Net Income-$22,739
Open 2014 Filing

Filings

Most recent year

2014 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$5,060
Liabilities
$0
Net assets
$5,060
Revenue
$0
Expenses
$22,739
Net income
-$22,739
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2014Detailed filing. Detailed filing data is available for this year.$5.06$0.00$5.06$0.00$22.7$22.7
2013Detailed filing. Detailed filing data is available for this year.$27.8$0.00$27.8$0.00$0.00$0.00
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$27.8$0.00$27.8$0.00
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
Nov 5, 2015
Return Version
2014v5.0
Gross Receipts
$0
Mission and Program Overview

Mission

The purpose of this corporation is clinical and scientific research for the treatment of endometriosis and infertility. Funds from the corporation will allow scientists to conduct laboratory and clinical research leading toward a cure and treatment for endometriosis and to promote novel treatment for infertility.

The purpose of this corporation is clinical and scientific research for the treatment of endometriosis and infertility. Funds from the corporation will allow scientists and physicians to conduct laboratory and clinical research leading toward a cure and treatment for endometriosis and to promote novel treatment for infertility.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$27,799$5,060▼ $22,739
Rtn Earn Endowment Incm Other Fnds$27,799$5,060▼ $22,739
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$27,799$5,060▼ $22,739
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Total Net Assets Fund Balance$27,799$5,060▼ $22,739
Total Liabilities and Net Assets / Fund Balance$27,799$5,060▼ $22,739
Compensation and Service Providers
Top Officer Pay81st percentile

Board Members and Trustees

NameTitle
Andrea VidaliDirector
Galina KarpenkoSecretary
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
Change in Net Assets
$-22,739
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$22,739
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Legal-$16,939-$16,939
Fees for Services Accounting-$5,800-$5,800
Total Functional Expenses$0$22,739$0$22,739
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

“Drs. Andrea vidali and galina karpenko practice medicine together.”

Form 990, Part VI, Section A, Line 6

“There are currently 2 stockholders.”

Form 990, Part VI, Section A, Line 8A

“No formal written documents were prepared by the governing body for meetings held or actions undertaken.”

Form 990, Part VI, Section A, Line 8B

“No formal written documents were prepared by any committee with authority to act on behalf of the governing body for meetings held or actions undertaken.”

Form 990, Part VI, Section B, Line 11

“No review was or will be conducted.”

Form 990, Part VI, Section C, Line 19

“The organization will make its governing documents, financial information and tax filings available to the public upon request.”

Filing and Contact Details

Filer

Filer Name
New York Metropolitan Endometriosis
EIN
26-1389461
Phone
6465157467
Address
41 S 5TH STREET NO 11, BROOKLYN, NY 11249

Signing Officer

Name
Andrea Vidali Md
Title
Director
Phone
2127503330
Signed
2015-11-05
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Andrea Vidali Md
Formed
2008
Legal Domicile
Ny
Voting Board Members
2
Independent Board Members
0
Employees
0
Volunteers
0

Preparer

Firm
Kreinces Rollins & Shanker LLC
Address
80 ROUTE 4 EAST SUITE 370, PARAMUS, NJ 07652
Preparer
Brad M Kreinces
Phone
2016557411
Raw XML Appendix250 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0THE PURPOSE OF THIS CORPORATION IS CLINICAL AND SCIENTIFIC RESEARCH FOR THE TREATMENT OF ENDOMETRIOSIS AND INFERTILITY. FUNDS FROM THE CORPORATION WILL ALLOW SCIENTISTS AND PHYSICIANS TO CONDUCT LABORATORY AND CLINICAL RESEARCH LEADING TOWARD A CURE AND TREATMENT FOR ENDOMETRIOSIS AND TO PROMOTE NOVEL TREATMENT FOR INFERTILITY.
IRS990/AddressChangeInd0X
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum02123178700
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt041 S 5TH STREET 11
IRS990/BooksInCareOfDetail/USAddress/CityNm0BROOKLYN
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd011249
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt027799
IRS990/CashNonInterestBearingGrp/EOYAmt05060
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd00
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt022739
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-22739
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt022739
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt00
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0GRANT ISSUED FOR RESEARCH FOR THE TREATMENT OF ENDOMETRIOSIS AND INFERTILITY
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt05800
IRS990/FeesForServicesAccountingGrp/TotalAmt05800
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt016939
IRS990/FeesForServicesLegalGrp/TotalAmt016939
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/PersonNm0ANDREA VIDALI
IRS990/Form990PartVIISectionAGrp/PersonNm1GALINA KARPENKO
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990ProvidedToGvrnBodyInd00
IRS990/FormationYr02008
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt02
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt00
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt00
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0NY
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd00
IRS990/MinutesOfGoverningBodyInd00
IRS990/MissionDesc0THE PURPOSE OF THIS CORPORATION IS CLINICAL AND SCIENTIFIC RESEARCH FOR THE TREATMENT OF ENDOMETRIOSIS AND INFERTILITY. FUNDS FROM THE CORPORATION WILL ALLOW SCIENTISTS TO CONDUCT LABORATORY AND CLINICAL RESEARCH LEADING TOWARD A CURE AND TREATMENT FOR ENDOMETRIOSIS AND TO PROMOTE NOVEL TREATMENT FOR INFERTILITY.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt027799
IRS990/NetAssetsOrFundBalancesEOYAmt05060
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/PartialLiquidationInd00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0ANDREA VIDALI MD
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt00
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt00
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt00
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt00
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt00
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt0-22739
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt027799
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt05060
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.00000
IRS990ScheduleA/PublicSupportPY170Pct01.00000
IRS990ScheduleA/PublicSupportTotal170Amt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsPY170Ind0X
IRS990ScheduleA/TotalSupportAmt00
IRS990/ScheduleBRequiredInd00
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DRS. ANDREA VIDALI AND GALINA KARPENKO PRACTICE MEDICINE TOGETHER.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THERE ARE CURRENTLY 2 STOCKHOLDERS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2NO FORMAL WRITTEN DOCUMENTS WERE PREPARED BY THE GOVERNING BODY FOR MEETINGS HELD OR ACTIONS UNDERTAKEN.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3NO FORMAL WRITTEN DOCUMENTS WERE PREPARED BY ANY COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY FOR MEETINGS HELD OR ACTIONS UNDERTAKEN.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4NO REVIEW WAS OR WILL BE CONDUCTED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5THE ORGANIZATION WILL MAKE ITS GOVERNING DOCUMENTS, FINANCIAL INFORMATION AND TAX FILINGS AVAILABLE TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION A, LINE 6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION A, LINE 8A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION A, LINE 8B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION B, LINE 11
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART VI, SECTION C, LINE 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0NY
IRS990/SubjectToProxyTaxInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TempOrPermanentEndowmentsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt027799
IRS990/TotalAssetsEOYAmt05060
IRS990/TotalAssetsGrp/BOYAmt027799
IRS990/TotalAssetsGrp/EOYAmt05060
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt022739
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt00
IRS990/TotalFunctionalExpensesGrp/TotalAmt022739
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt027799
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt05060
IRS990/TotalOtherCompensationAmt00
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt00
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt00
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt027799
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt05060
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt041 S 5TH STREET NO 11
IRS990/USAddress/CityNm0BROOKLYN
IRS990/USAddress/StateAbbreviationCd0NY
IRS990/USAddress/ZIPCd011249
IRS990/VotingMembersGoverningBodyCnt02
IRS990/VotingMembersIndependentCnt00
IRS990/WebsiteAddressTxt0N/A
IRS990/WhistleblowerPolicyInd00
ReturnHeader/BuildTS02016-02-25 16:41:14Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ANDREA VIDALI MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum02127503330
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-11-05
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0NEW YORK METROPOLITAN ENDOMETRIOSIS
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0RESEARCH INCORPORATED
ReturnHeader/Filer/BusinessNameControlTxt0NEWY
ReturnHeader/Filer/EIN0261389461
ReturnHeader/Filer/PhoneNum06465157467
ReturnHeader/Filer/USAddress/AddressLine1Txt041 S 5TH STREET NO 11
ReturnHeader/Filer/USAddress/CityNm0BROOKLYN
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd011249
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0202002973
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0KREINCES ROLLINS & SHANKER LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt080 ROUTE 4 EAST SUITE 370
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0PARAMUS
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NJ
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd007652
ReturnHeader/PreparerPersonGrp/PhoneNum02016557411
ReturnHeader/PreparerPersonGrp/PreparationDt02015-11-05
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0BRAD M KREINCES
ReturnHeader/ReturnTs02015-11-16T10:07:35-06:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.